StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: IBM (IBM) Estiamtes, PT Lowered to $112 at UBS; 'Not Immune to Macro, FX, Slowing IT'
September 28, 2022 7:36 AM
(Updated - September 28, 2022 8:13 AM EDT)
UBS analyst David Vogt lowered the price target on IBM (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
IBM (IBM) Not Immune to Macro Headwinds- UBS
September 28, 2022 2:05 PM